Skip to main content
. 2023 Jun 23;23(4):319–326. doi: 10.1097/ACI.0000000000000922

FIGURE 1.

FIGURE 1

Suggested algorithm for selecting a biologic agent for pediatric severe asthma. Note: Agents ordered alphabetically within each group. EOS, serum eosinophils; FeNO, fractional exhaled nitric oxide. 1Omalizumab only for allergic asthma (all other agents can be considered for both allergic and nonallergic asthma). 2Dupilumab only if EOS less than 1500 cells/μl.